A Non-Interventional Study of Bosutinib in Patients With Previously Treated Chronic Phase Chronic Myelogenous Leukemia (CML)

23/12/2013
30/03/2024
EU PAS number:
EUPAS5461
Study
Finalised
Documents
Study protocol
Initial protocol
English (996.13 KB - PDF) View document
Study results
Study report
Study report
English (7.41 MB - PDF) View document
Other information